Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
Authors:
Open Access
- 24 November 2025
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1344
Abstract
Background: Oral squamous cell carcinoma (OSCC) represents a highly malignant form of cancer characterized by molecular heterogeneity and unsatisfactory treatment outcomes, with approximately 50% of patients experiencing local recurrence and distant metastasis following therapy. Given that metastasis is the most critical determinant of OSCC prognosis, enhancing the precision of clinical interventions and identifying therapeutic targets are of paramount importance. In view of this, this study is the first to develop a machine-learning-based prognostic model integrating epithelial-mesenchymal transition (EMT), anoikis, and basement membrane remodeling genes. Methods: We systematically evaluated 78 algorithm and parameter combinations to identify a robust prognostic model, stratifying patients into High- and Low-risk groups. Kaplan-Meier survival curves and receiver operating characteristic (ROC) analyses were employed to evaluate the predictive performance of this model. Functional enrichment of differentially expressed genes (DEGs) between risk groups revealed key OSCC progression mechanisms. We further analyzed tumor mutation burden, immune microenvironment features, and identified candidate drugs through sensitivity prediction and molecular docking. Results: The identified 13-gene prognostic model effectively stratified patients into high- and low-risk groups, demonstrating strong predictive power for overall survival: the high-risk group exhibited worse prognosis. Mutation landscape demonstrated significant genetic variability within these model genes, which provided insights into the association between elevated tumor mutational burden and adverse prognostic outcomes. Immune landscape revealed a distinct tumor microenvironment: high-risk group exhibited altered immune cell infiltration, along with increased tumor purity, reduced ESTIMATE score and poorer anticipated response to immunotherapy. Finally, seven promising therapeutic candidates were identified through integrated computational drug screening. Conclusion: We developed and validated a 13-gene prognostic model that integrates metastasis-related processes, improves survival prediction, and identifies therapeutic opportunities in OSCC.Keywords
This publication has 88 references indexed in Scilit:
- Sorafenib resistance and therapeutic strategies in hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025
- Microenvironment-based immunotherapy in oral cancer: a comprehensive reviewMedical Oncology, 2025
- SLUG‐related partial epithelial‐to‐mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survivalMolecular Oncology, 2021
- The dual role of mast cells in tumor fateCancer Letters, 2018
- Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous CarcinomasCell Reports, 2018
- Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell CarcinomaPathology and Oncology Research, 2016
- Sustained overexpression of Redd1 leads to Akt activation involved in cell survivalCancer Letters, 2013
- Emerging insights into head and neck cancer metastasisHead & Neck, 2012
- Transforming growth factor-β and the hallmarks of cancerCellular Signalling, 2011
- Activation of naive, memory and effector T cellsCurrent Opinion in Immunology, 1994